1.17
-0.01(-0.85%)
Currency In USD
| Previous Close | 1.18 |
| Open | 1.18 |
| Day High | 1.19 |
| Day Low | 1.14 |
| 52-Week High | 4.46 |
| 52-Week Low | 1.12 |
| Volume | 1.75M |
| Average Volume | 1.06M |
| Market Cap | 105.68M |
| PE | -1.6 |
| EPS | -0.73 |
| Moving Average 50 Days | 1.58 |
| Moving Average 200 Days | 2.25 |
| Change | -0.01 |
If you invested $1000 in Codexis, Inc. (CDXS) 10 years ago, it would be worth $282.61 as of February 21, 2026 at a share price of $1.17. Whereas If you bought $1000 worth of Codexis, Inc. (CDXS) shares 5 years ago, it would be worth $46.65 as of February 21, 2026 at a share price of $1.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Codexis to Participate in TD Cowen 46th Annual Health Care Conference
GlobeNewswire Inc.
Feb 17, 2026 2:00 PM GMT
REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the TD Cowen 4
Codexis Achieves ISO 9001:2015 Certification
GlobeNewswire Inc.
Feb 10, 2026 2:00 PM GMT
REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned its ISO 9001:2015 certification
Codexis Announces Signing of Lease for GMP Manufacturing Facility
GlobeNewswire Inc.
Nov 10, 2025 2:00 PM GMT
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 3